The future of medical cannabis development in Europe
European Pharmaceutical Review
JULY 13, 2023
5 When these medicines are prescribed to patients, we can use feedback from the real-world data that documents clinical outcomes, efficacy measures, patient-reported outcomes, and adverse events. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry.
98 
Let's personalize your content